These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 34472721)
21. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer. Cheng S; Wang G; Wang Y; Cai L; Qian K; Ju L; Liu X; Xiao Y; Wang X Clin Sci (Lond); 2019 Aug; 133(15):1745-1758. PubMed ID: 31358595 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Cha SH; Hu Z; Chohnan S; Lane MD Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972 [TBL] [Abstract][Full Text] [Related]
23. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism. Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254 [TBL] [Abstract][Full Text] [Related]
24. Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemotherapy and phototherapy in vitro. Sorg C; Schmid E; Bortel N; Fuchs J; Ellerkamp V Int J Oncol; 2021 Feb; 58(2):266-274. PubMed ID: 33491749 [TBL] [Abstract][Full Text] [Related]
25. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910 [TBL] [Abstract][Full Text] [Related]
26. Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models. Zhang L; Marrano P; Wu B; Kumar S; Thorner P; Baruchel S Clin Cancer Res; 2016 Jun; 22(11):2697-708. PubMed ID: 26719428 [TBL] [Abstract][Full Text] [Related]
33. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737 [TBL] [Abstract][Full Text] [Related]
34. A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model. Zhong WB; Tsai YC; Chin LH; Tseng JH; Tang LW; Horng S; Fan YC; Hsu SP Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932104 [TBL] [Abstract][Full Text] [Related]
35. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. Park H; Kaushik VK; Constant S; Prentki M; Przybytkowski E; Ruderman NB; Saha AK J Biol Chem; 2002 Sep; 277(36):32571-7. PubMed ID: 12065578 [TBL] [Abstract][Full Text] [Related]
36. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Schlaepfer IR; Rider L; Rodrigues LU; Gijón MA; Pac CT; Romero L; Cimic A; Sirintrapun SJ; Glodé LM; Eckel RH; Cramer SD Mol Cancer Ther; 2014 Oct; 13(10):2361-71. PubMed ID: 25122071 [TBL] [Abstract][Full Text] [Related]
37. A role for hypothalamic malonyl-CoA in the control of food intake. Hu Z; Dai Y; Prentki M; Chohnan S; Lane MD J Biol Chem; 2005 Dec; 280(48):39681-3. PubMed ID: 16219771 [TBL] [Abstract][Full Text] [Related]
39. Malonyl-CoA, a key signaling molecule in mammalian cells. Saggerson D Annu Rev Nutr; 2008; 28():253-72. PubMed ID: 18598135 [TBL] [Abstract][Full Text] [Related]
40. Hypothalamic malonyl-coenzyme A and the control of energy balance. Wolfgang MJ; Lane MD Mol Endocrinol; 2008 Sep; 22(9):2012-20. PubMed ID: 18356287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]